IL24 and ovarian carcinoma: Recent in vitro studies from our laboratory and those performed by others showed that mda-7/IL-24 can suppress ovarian cancer cell growth in vitro and is dependent on the Fas/FasL or stress activated p38 mitogen-activated protein kinase (MAPK) pathway [4,5].